The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study

Background and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who ref...

Full description

Saved in:
Bibliographic Details
Main Authors: Lihan Zhou, Sijia Wang, Jian Li, Jie Zhong, Ling Zhang, Ruizhe Shen, Bielike Kouken, Chunhua Zhou, Qi Wang, Yuting Qian, Duowu Zou, Ye Chu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/6934594
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561393635688448
author Lihan Zhou
Sijia Wang
Jian Li
Jie Zhong
Ling Zhang
Ruizhe Shen
Bielike Kouken
Chunhua Zhou
Qi Wang
Yuting Qian
Duowu Zou
Ye Chu
author_facet Lihan Zhou
Sijia Wang
Jian Li
Jie Zhong
Ling Zhang
Ruizhe Shen
Bielike Kouken
Chunhua Zhou
Qi Wang
Yuting Qian
Duowu Zou
Ye Chu
author_sort Lihan Zhou
collection DOAJ
description Background and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who refused C-EGD. Methods. We performed a retrospective study of 76794 consecutive symptomatic outpatients from January 2014 to October 2019. A total of 2318 adults (F/M=1064/1254) in the MCCG group who refused C-EGD were matched with adults in the C-EGD group using propensity-score matching (PSM). The detection rates of abnormalities were analyzed to explore the application of MCCG in symptomatic patients. Results. Our study demonstrated a prevalence of gastric ulcers (GUs) in patients with functional dyspepsia- (FD-) like symptoms of 8.14%. The detection rate of esophagitis and Barrett’s esophagus was higher in patients with typical gastroesophageal reflux disease (GERD) symptoms than in patients in the other four groups (P<0.01). The detection rates of gastric ulcers in the five groups (abdominal pain, bloating, heartburn, follow-up, and bleeding) were significantly different (P=0.015). The total detection rate of gastric ulcers in symptomatic patients was 9.7%. A total of 7 advanced carcinomas were detected by MCCG and confirmed by endoscopic or surgical biopsy. The advanced gastric cancer detection rate was not significantly different between the MCCG group and the C-EGD matched group in terms of nonhematemesis GI bleeding (2 vs. 2, P=1.00). In addition, the overall focal lesion detection rate in the MCCG group was superior to that in the C-EGD matched group (224 vs. 184, P=0.038). MCCG gained a clinically meaningful small bowel diagnostic yield of 54.8% (17/31) out of 31 cases of suspected small bowel bleeding. No patient reported capsule retention at the two-week follow-up. Conclusion. MCCG is well tolerated, safe, and technically feasible and has a considerable diagnostic yield. The overall gastric diagnostic yield of gastric focal lesions with MCCG was comparable to that with C-EGD. MCCG offered a supplementary diagnosis in patients who had a previously undiagnostic C-EGD, indicating that MCCG could play an important role in the routine monitoring and follow-up of outpatient. MCCG shows its safety and efficiency in symptomatic outpatient applications.
format Article
id doaj-art-e8cdffc1d9124e998b2cc440b8cd0bdd
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-e8cdffc1d9124e998b2cc440b8cd0bdd2025-02-03T01:25:18ZengWileyGastroenterology Research and Practice1687-61211687-630X2021-01-01202110.1155/2021/69345946934594The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational StudyLihan Zhou0Sijia Wang1Jian Li2Jie Zhong3Ling Zhang4Ruizhe Shen5Bielike Kouken6Chunhua Zhou7Qi Wang8Yuting Qian9Duowu Zou10Ye Chu11Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaClinical Research Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaBackground and Aims. Screening for gastric diseases in symptomatic outpatients with conventional esophagogastroduodenoscopy (C-EGD) is expensive and has poor compliance. We aimed to explore the efficiency and safety of magnetic-controlled capsule gastroscopy (MCCG) in symptomatic outpatients who refused C-EGD. Methods. We performed a retrospective study of 76794 consecutive symptomatic outpatients from January 2014 to October 2019. A total of 2318 adults (F/M=1064/1254) in the MCCG group who refused C-EGD were matched with adults in the C-EGD group using propensity-score matching (PSM). The detection rates of abnormalities were analyzed to explore the application of MCCG in symptomatic patients. Results. Our study demonstrated a prevalence of gastric ulcers (GUs) in patients with functional dyspepsia- (FD-) like symptoms of 8.14%. The detection rate of esophagitis and Barrett’s esophagus was higher in patients with typical gastroesophageal reflux disease (GERD) symptoms than in patients in the other four groups (P<0.01). The detection rates of gastric ulcers in the five groups (abdominal pain, bloating, heartburn, follow-up, and bleeding) were significantly different (P=0.015). The total detection rate of gastric ulcers in symptomatic patients was 9.7%. A total of 7 advanced carcinomas were detected by MCCG and confirmed by endoscopic or surgical biopsy. The advanced gastric cancer detection rate was not significantly different between the MCCG group and the C-EGD matched group in terms of nonhematemesis GI bleeding (2 vs. 2, P=1.00). In addition, the overall focal lesion detection rate in the MCCG group was superior to that in the C-EGD matched group (224 vs. 184, P=0.038). MCCG gained a clinically meaningful small bowel diagnostic yield of 54.8% (17/31) out of 31 cases of suspected small bowel bleeding. No patient reported capsule retention at the two-week follow-up. Conclusion. MCCG is well tolerated, safe, and technically feasible and has a considerable diagnostic yield. The overall gastric diagnostic yield of gastric focal lesions with MCCG was comparable to that with C-EGD. MCCG offered a supplementary diagnosis in patients who had a previously undiagnostic C-EGD, indicating that MCCG could play an important role in the routine monitoring and follow-up of outpatient. MCCG shows its safety and efficiency in symptomatic outpatient applications.http://dx.doi.org/10.1155/2021/6934594
spellingShingle Lihan Zhou
Sijia Wang
Jian Li
Jie Zhong
Ling Zhang
Ruizhe Shen
Bielike Kouken
Chunhua Zhou
Qi Wang
Yuting Qian
Duowu Zou
Ye Chu
The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
Gastroenterology Research and Practice
title The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
title_full The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
title_fullStr The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
title_full_unstemmed The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
title_short The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study
title_sort application of magnetic controlled capsule gastroscopy in patients refusing c egd a single center 5 year observational study
url http://dx.doi.org/10.1155/2021/6934594
work_keys_str_mv AT lihanzhou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT sijiawang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT jianli theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT jiezhong theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT lingzhang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT ruizheshen theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT bielikekouken theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT chunhuazhou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT qiwang theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT yutingqian theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT duowuzou theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT yechu theapplicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT lihanzhou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT sijiawang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT jianli applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT jiezhong applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT lingzhang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT ruizheshen applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT bielikekouken applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT chunhuazhou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT qiwang applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT yutingqian applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT duowuzou applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy
AT yechu applicationofmagneticcontrolledcapsulegastroscopyinpatientsrefusingcegdasinglecenter5yearobservationalstudy